METAvivor Announces Founders' Challenge

This year is METAvivor's 10th year anniversary and the organization's goal is to exceed $10 million for metastatic breast cancer research funding in 2019.
 
 
Spread the Word
Listed Under

Tag:
Advanced Breast Cancer

Industry:
Health

Location:
Annapolis - Maryland - US

Subject:
Projects

ANNAPOLIS, Md. - March 23, 2019 - PRLog -- METAvivor Research and Support Inc., a non-profit organization dedicated to funding research grants for Stage IV metastatic breast cancer (MBC), announces the Founders Challenge, "Ten IV Ten."

"Metavivor has awarded $7.4 million in metastatic breast cancer research since 2009. Our goal for our 10th year anniversary is to target the $10 million mark by summer," according to Metavivor president, Beth Fairchild.  "We are also adding a $500,000 Founders' Research Award to our existing $200,000 Translational Grant Awards and our $50,000 Early Career Investigator Awards. We are thankful to our donors and supporters who have worked so hard to help Metavivor fund this crucial research, but we still have work to do."

Metavivor asks everyone who is interested in raising money for metastatic breast cancer research to participate in the "Founder's Ten IV Ten Challenge," a target campaign dedicated to the three deceased founders of Metavivor, by visiting www.founderschallenge.org to set-up their personal fundraising page or contribute to the campaign.  Metavivor hopes to raise $2.6 million by summer to reach its "Ten IV Ten" goal.

Dian "CJ" Corneliussen, the only living founder of METAvivor explained, "The founders of METAvivor conceived of and created the first, and as far as I know, still the only competitive stage IV research funding program in existence. Moreover, we did this at a time when neither newspapers nor magazines would publish articles on our disease; there was virtually no relevant literature; stage IV patients were unwelcome at conferences; Facebook and Twitter had not gone public and were limited in scope; Google had a hard time finding anything under "metastasis" and the NCI was spending less than 0.5% of its $5 billion cancer budget on metastasis – all cancer types combined.

"Having already connected with the Metastasis Research Society, I knew what was needed. So, on January 13, 2009 I handpicked three women from the support group I'd founded a year earlier and asked them to join me in founding a non-profit.  They were Karen Presswood, a Paragon Award Winning CVS pharmacist, Avis Halberstadt, a math teacher and SAT tutor and Rhonda Rhodes, Founder and CEO of a health care consulting firm.  Within days Avis had crafted the very clever name of METAvivor and our goal was set – to significantly extend and ultimately save life while pursuing improved quality of life at every turn."

"Thanks to Avis's fundraising skills, we soon established an annual fundraising program of Holiday Home Tours, Sprint Triathlons (Kayak – Bike – Run) and Authors' Luncheons.  Within one year, on January 13, 2010, we award our first grant of $55,000.  That amount has increased annually ever since.  Tragically, neither Karen nor Rhonda survived long enough to see our first grant awarded.  Avis passed away in 2014."

"Great care was taken to establish a program that would succeed and endure. Creating a viable research funding program that attracted innovative and progressive proposals while ensuring they were expertly prioritized for funding was our top priority. That program, along with our awareness campaigns and Peer to Peer support program remain hallmarks of METAvivor. Join us in honoring the efforts of Rhonda Rhodes, Avis Halberstadt and Karen Presswood and donate generously to the Founders' Challenge in their memory.  Thank you."

Metastatic breast cancer, also known as Stage IV or advanced stage cancer, is the spread of breast cancer to other parts of the body -- most commonly to the bones, liver, lungs and/or brain. At least five percent of patients are diagnosed de nova with metastatic breast cancer, 30% of earlier stage breast cancer patients metastasize, and 97 – 98% die as a result, with the average survival after diagnosis being two to three years. In the U.S., only 2-5% of all cancer research funds are dedicated to Stage IV cancer research – yet 100% of all breast cancer deaths are caused by a metastasis.

To participate in the Metavivor Founder's Challenge, visit www.founderschallenge.org

ABOUT METAVIVOR

METAvivor Research and Support Inc. is an Annapolis-based, 501(c)(3), volunteer-led, non-profit organization founded by metastatic breast cancer (MBC) patients in 2009.  The focus of the organization is to fund critical research that will lead to advances in treatment options, quality of life and survival for patients diagnosed with MBC.  METAvivor is the only national organization with a peer-reviewed grant program aimed at exclusively funding MBC research, and 100% of all donations go to fund research.

METAvivor also raises awareness of MBC, provides support and education for people living with this disease, and offers opportunities for others to help make a difference for the metastatic community.

Visit us at http://www.METAvivor.org (https://www.metavivor.org), and follow us on Facebook (https://www.facebook.com/metavivor/?ref=aymt_homepage_pan...), Twitter (https://Twitter.com/metavivor) and Instagram (https:/Instagram/Metavivor/).

Contact
Sonya Negley
***@metavivor.org
End
Email:***@metavivor.org Email Verified
Tags:Advanced Breast Cancer
Industry:Health
Location:Annapolis - Maryland - United States
Subject:Projects
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
METAvivor Research and Support, Inc PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share